Skip to content
Recall Observatory FDA recall evidence

Drug product

Copaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33 Alcohol Preps (swabs) per box, Marketed by: TEVA Neuroscience, Inc., Kansas City, MO 64131; Distributed by: TEVA Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30

D-249-2013

December 05, 2012

Class II

Product summary

Firm
Teva Pharmaceuticals USA, Inc.
Event
Event 63819
Status
Terminated
Classification
Class II
Quantity
6,692 boxes
Official record key
drug-enforcement:D-249-2013

Official wording

Reason: Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.

Code information: Lot P53847, Exp 01/14

Distribution pattern: Nationwide

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Substance